Cannabics Pharmaceuticals, a company developing a platform that leverages novel drug-screening tools and artificial intelligence to create customized cannabinoid-based cancer therapies, published the final results of a pilot study that could potentially treat a common complication of cancer using the company’s dosage-controlled cannabis capsules in the Journal of Integrative Cancer Therapies, the company announced last […]

Can an AI-powered robot tend to cannabis plants better than skilled manual labor? Israeli startup says yes.

Cannabics Pharmaceuticals, which develops personalized cannabinoid medicine focused on cancer, and is already partnered by Seedo, puts up the funds.

Eroll Grow Tech, Cannabics Pharmaceuticals team up to create the first automated device to grow medical cannabis at home.